https://scholars.lib.ntu.edu.tw/handle/123456789/553005
Title: | Incidence and impact of low-level viremia among people living with HIV who received protease inhibitor- or dolutegravir-based antiretroviral therapy | Authors: | Chen, Guan-Jhou HSIN-YUN SUN SUI-YUAN CHANG ARISTINE CHENG YU-SHAN HUANG YI-CHIA HUANG Su, Yi-Ching Liu, Wen-Chun Hung, Chien-Ching CHIEN-CHING HUNG |
Keywords: | Genetic barrier; Integrase strand transfer inhibitor; Nucleoside reverse transcriptase inhibitor; Resistance-associated mutation; Virological failure | Issue Date: | 13-Feb-2021 | Journal Volume: | 105 | Source: | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | Abstract: | The impact of very low-level viremia (VLLV) and low-level viremia (LLV) are rarely investigated among people living with HIV (PLWH) receiving dolutegravir- vs protease inhibitor (PI)-based antiretroviral therapy (ART). |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/553005 | ISSN: | 12019712 | DOI: | 10.1016/j.ijid.2021.02.045 | SDG/Keyword: | abacavir; atazanavir; darunavir; dolutegravir; lamivudine; lopinavir; nonnucleoside reverse transcriptase inhibitor; proteinase inhibitor; RNA directed DNA polymerase inhibitor; tenofovir disoproxil; virus RNA; zidovudine; antiretrovirus agent; dolutegravir; fused heterocyclic rings; integrase inhibitor; oxazine derivative; piperazine derivative; proteinase inhibitor; pyridone derivative; adult; antiretroviral therapy; antiviral resistance; Article; CD4 lymphocyte count; cohort analysis; controlled study; drug substitution; drug withdrawal; female; follow up; human; Human immunodeficiency virus infected patient; Human immunodeficiency virus infection; human tissue; incidence; major clinical study; male; metabolic syndrome X; observational study; retrospective study; risk factor; treatment duration; unspecified side effect; viremia; virus load; clinical trial; Human immunodeficiency virus infection; middle aged; viremia; virology; virus load; Adult; Anti-Retroviral Agents; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; Humans; Incidence; Male; Middle Aged; Oxazines; Piperazines; Protease Inhibitors; Pyridones; Viral Load; Viremia |
Appears in Collections: | 醫學檢驗暨生物技術學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.